These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26476250)

  • 1. Psoriasis and Cardiovascular Disease.
    Shahwan KT; Kimball AB
    Med Clin North Am; 2015 Nov; 99(6):1227-42. PubMed ID: 26476250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis.
    Burfield L; Burden AD
    J R Coll Physicians Edinb; 2013; 43(4):334-8; quiz 339. PubMed ID: 24350319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cardiovascular disorders in psoriasis patients: current and future.
    Tablazon IL; Al-Dabagh A; Davis SA; Feldman SR
    Am J Clin Dermatol; 2013 Feb; 14(1):1-7. PubMed ID: 23329076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
    Boehncke WH; Boehncke S
    G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence.
    Johnsson H; McInnes IB; Sattar N
    Ann Rheum Dis; 2012 Apr; 71(4):480-3. PubMed ID: 22294632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treating psoriasis on cardiovascular co-morbidities: focus on TNF inhibitors.
    Famenini S; Sako EY; Wu JJ
    Am J Clin Dermatol; 2014 Feb; 15(1):45-50. PubMed ID: 24281789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy.
    Su YS; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):876-83. PubMed ID: 22702656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Ryan C; Kirby B
    Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease.
    Torres T; Sales R; Vasconcelos C; Martins da Silva B; Selores M
    J Dermatol; 2013 Nov; 40(11):923-6. PubMed ID: 24128349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.
    Tobin AM; Veale DJ; Fitzgerald O; Rogers S; Collins P; O'Shea D; Kirby B
    J Rheumatol; 2010 Jul; 37(7):1386-94. PubMed ID: 20472927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis and cardiovascular disorders.
    Frieder J; Ryan C
    G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifiable lifestyle factors associated with metabolic syndrome in patients with psoriasis.
    Ahdout J; Kotlerman J; Elashoff D; Kim J; Chiu MW
    Clin Exp Dermatol; 2012 Jul; 37(5):477-83. PubMed ID: 22712856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular health for patients with psoriasis: a précis for front-line clinicians.
    Federman DG; Shelling ML; Prodanovich S; Gunderson CG; Kirsner RS
    Ostomy Wound Manage; 2009 May; 55(5):38-47. PubMed ID: 19471047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidities in patients with psoriasis.
    Gottlieb AB; Dann F
    Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.
    Boehncke WH; Boehncke S
    Curr Rheumatol Rep; 2012 Aug; 14(4):343-8. PubMed ID: 22562431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's new in the management of psoriasis?
    Kinney MA; Feldman SR
    G Ital Dermatol Venereol; 2009 Apr; 144(2):103-17. PubMed ID: 19357619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research gaps in psoriasis: opportunities for future studies.
    Ryan C; Korman NJ; Gelfand JM; Lim HW; Elmets CA; Feldman SR; Gottlieb AB; Koo JY; Lebwohl M; Leonardi CL; Van Voorhees AS; Bhushan R; Menter A
    J Am Acad Dermatol; 2014 Jan; 70(1):146-67. PubMed ID: 24126079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk and psoriasis: beyond the traditional risk factors.
    Coumbe AG; Pritzker MR; Duprez DA
    Am J Med; 2014 Jan; 127(1):12-8. PubMed ID: 24161194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psoriasis and cardiovascular disease].
    Torres T; Sales R; Vasconcelos C; Selores M
    Acta Med Port; 2013; 26(5):601-7. PubMed ID: 24192101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.